1978 Nobel Prize in Physiology or Medicine
Reason for Award
for the discovery of restriction enzymes and their application to problems of molecular genetics
Laureates
United States of America
United States of America
Switzerland
Explanation
Inside our bodies is a “book” of genes called DNA. In 1978, scientists who won the Nobel Prize discovered an enzyme, like a pair of scissors, that can cut DNA. This enzyme, called a restriction enzyme, is a tool bacteria use to defend themselves from viruses. Researchers learned to cut and join DNA wherever they wanted, just like taking apart and rebuilding LEGO bricks. Thanks to this, we can now study genes closely and create useful medicines. Today these enzymes help doctors diagnose diseases and make new drugs.
Related Keywords
restriction enzyme
An enzyme that recognizes and cleaves DNA at specific nucleotide sequences. It evolved in bacteria as a defense against invading phages. Today it is indispensable for molecular cloning and DNA fingerprinting. Recognition sites are usually palindromic, producing sticky or blunt ends after cleavage. Thousands of variants are commercially available and used daily in molecular biology labs.
recognition sequence
A short stretch of DNA where a restriction enzyme binds and cleaves. Typically 4–8 base pairs long. Mismatches greatly reduce cleavage efficiency. Most sites are palindromic, leading to complementary sticky ends. Knowledge of recognition sequences aids enzyme engineering and bioinformatic genome analysis.
molecular cloning
A technique that inserts a gene of interest into a plasmid vector and amplifies it in a host cell. The classic protocol uses restriction enzymes to cut vector and insert, then DNA ligase to seal the nicks. Since the 1970s, it has enabled recombinant insulin, vaccines, and many other bioproducts. Modern synthetic biology and gene therapy vectors still rely on its principles, even though PCR and Gibson assembly have added flexibility.
host restriction-modification system
A bacterial defense mechanism that methylates self DNA while cleaving unmethylated foreign DNA. A restriction enzyme works in tandem with a DNA methyltransferase. The system diversified through an evolutionary arms race with phages. Its study laid groundwork for epigenetics and foreshadowed CRISPR research. Industrial strains are often engineered to modulate or bypass this system to improve transformation efficiency.
DNA ligase
An enzyme that seals DNA breaks by forming phosphodiester bonds. It is essential for re-joining sticky ends generated by restriction enzymes. Beyond its natural role in nick repair, it became a key reagent in molecular cloning. Both ATP-dependent and NAD+-dependent forms exist, each with distinct kinetics and temperature profiles. Modern one-pot assembly methods still rely on ligase activity.
genome mapping
The process of determining positions of genes and markers along chromosomes. Physical maps were initially built using RFLP analysis, pulse-field electrophoresis, and other restriction-based techniques. Early stages of the Human Genome Project combined BAC libraries with restriction analysis to create scaffold maps. Mapping provides essential context before full sequencing. Even in the NGS era, it remains valuable for structural variant studies and long-read assembly validation.
recombinant DNA technology
A method that cuts and joins DNA from different organisms to create novel sequences. The 1973 Cohen-Boyer experiment marked its practical beginning, relying on restriction enzymes and DNA ligase. Applications span medicine, agriculture, and environmental science, driving a vast bio-industry. Ethical and safety debates trace back to the Asilomar conference and continue today. Modern genome editing is essentially an extension of recombinant DNA principles.